X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $51.50 | -1,035 | 68,576 | -1% | -$53,303 | ||||||
2024-08-26 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $53.19 | -3,000 | 69,611 | -4% | -$159,570 | ||||||
2024-08-12 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $47.68 | -3,000 | 72,611 | -4% | -$143,040 | ||||||
2024-07-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $53.43 | -3,000 | 75,611 | -4% | -$160,290 | ||||||
2024-07-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $48.55 | -3,000 | 78,611 | -4% | -$145,650 | ||||||
2024-06-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $45.37 | -3,000 | 80,643 | -4% | -$136,110 | ||||||
2024-06-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $43.86 | -3,000 | 83,643 | -3% | -$131,580 | ||||||
2024-05-28 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $47.49 | -3,000 | 86,643 | -3% | -$142,470 | ||||||
2024-05-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $49.43 | -3,000 | 89,643 | -3% | -$148,290 | ||||||
2024-01-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $37.26 | -3,000 | 73,298 | -4% | -$111,780 | ||||||
2024-01-10 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $37.65 | -3,000 | 76,298 | -4% | -$112,950 | ||||||
2023-12-26 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $35.89 | -3,000 | 79,298 | -4% | -$107,670 | ||||||
2023-12-11 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $32.87 | -3,000 | 82,298 | -4% | -$98,610 | ||||||
2023-11-27 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $31.84 | -3,000 | 85,298 | -3% | -$95,520 | ||||||
2023-02-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $19.59 | -3,126 | 64,689 | -5% | -$61,238 | ||||||
2023-01-25 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $21.07 | -8,336 | 67,815 | -11% | -$175,640 | ||||||
2023-01-17 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.00 | -3,126 | 76,151 | -4% | -$56,268 | ||||||
2023-01-03 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $18.35 | -3,126 | 79,277 | -4% | -$57,362 | ||||||
2022-12-15 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $16.00 | -3,126 | 82,403 | -4% | -$50,016 | ||||||
2022-12-01 | CRNX | Betz Stephen F. | Chief Scientific Officer | S - Sale | $17.84 | -3,126 | 84,968 | -4% | -$55,768 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |